Laddar...
Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery
Disease progression prediction and therapeutic drug target discovery for Coronavirus disease 2019 (COVID-19) are particularly important, as there is still no effective strategy for severe COVID-19 patient treatment. Herein, we performed multi-platform omics analysis of serial plasma and urine sample...
Sparad:
| I publikationen: | Signal Transduct Target Ther |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group UK
2021
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8047575/ https://ncbi.nlm.nih.gov/pubmed/33859163 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41392-021-00508-4 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|